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Abstract: Protein design will ultimately allow for the creation
of artificial enzymes with novel functions and unprecedented
stability. To test our current mastery of natures approach to
catalysis, a ZnII metalloenzyme was prepared using de novo
design. a3DH3 folds into a stable single-stranded three-helix
bundle and binds ZnII with high affinity using His3O coordi-
nation. The resulting metalloenzyme catalyzes the hydration of
CO2 better than any small molecule model of carbonic
anhydrase and with an efficiency within 1400-fold of the
fastest carbonic anhydrase isoform, CAII, and 11-fold of
CAIII.
Protein design is an increasingly popular approach for
studying and modeling the structure–function relationships in
proteins.[1] There is a growing interest in the development of
artificial enzymes that can perform with the efficiency of
natural enzymes toward reactions not normally seen in
nature. Specifically, artificial metalloenzymes are important
design targets because over one-third of natural proteins use
metal ions for structural, catalytic, and/or electron-transfer
functions. There are two main metalloprotein design strat-
egies: protein redesign and de novo design. The former
approach involves the introduction of a metal-binding site
into an existing, stable protein. The latter relies on first
principles to design well-defined structures from amino acid
sequences not found in nature. De novo design is challenging
owing to its requirement for complete control over folding
and function, but it can lead to significant insight into the
nature of metal–enzyme interactions. Several recent exam-
ples showcase the power of de novo design in creating
metalloenzymes with enzymatic activity for ester hydroly-
sis,[2–5] nitrite reduction,[6] oxidation,[7,8] and N-hydroxyl-
ation.[9]
One test of our current mastery of protein design is to
model the activity of a natural enzyme. Carbonic anhydrase,
which is ubiquitous in animals, plants, and bacteria, is
essential for respiration, vision, regulation of acid–base
equilibrium, and many other processes. One of the most
efficient enzymes in nature, human carbonic anhydrase II
(CAII), catalyzes the reversible hydration of CO2 with
a catalytic efficiency approaching the diffusion limit in
water. The importance of this metalloenzyme, in conjunction
with its well-studied mechanism, solid-state structure, and
inhibition, make it a highly appealing, yet challenging, target
to assess our ability to replicate the activity of a natural
metalloenzyme in a simplified system.
Previously, we presented a highly efficient CA-mimic by
modeling the active site within a de novo designed three-
stranded coiled-coil (3SCC). The bifunctional
HgIISZn
II
N(TRIL9CL23H)3 closely models the structure of
the ZnIIHis3OH primary coordination sphere of CAII, yet
places it within a very different fold (a-helices vs b-sheets in
CAII), and contains an additional HgIICys3 site which
provides structural stability. The metalloenzyme catalyzes
CO2 hydration with an efficiency comparable to some
naturally occurring CAs and within 350-fold of the fastest
isozyme, CAII. While this is the fastest CA-model to date,
improvements to the system are limited by the inherent
symmetry resulting from the self-assembly of three parallel a-
helices. Not only are antiparallel helices more typical in
nature,[10] but CAII contains a network of H-bonds that
cannot currently be modeled in this system. Therefore, a new
approach is required.
To allow for asymmetry in the secondary sphere of the
active site, we have designed a metalloenzyme starting from
a3D, a de novo single-stranded antiparallel three-helix
bundle. Designed by DeGrado and co-workers,[13] this 73
amino acid protein folds with native protein-like stability, is
tolerant of mutations within the hydrophobic core,[14] and has
been structurally characterized by NMR spectroscopy.[12]
Previously, our lab incorporated a Cys3 metal binding site
near the C-terminus of a3D and showed that the resulting
protein, a3DIV, binds Hg
II, PbII, and CdII with high affinity in
coordination geometries previously identified within the TRI
family of 3SCCs.[15] Herein, we report a new metalloenzyme,
a3DH3, which contains a His3 site that, upon binding Zn
II,
catalyzes the hydration of CO2 (Figure 1).
a3DH3 differs from a3D in that three leucine residues
were replaced with histidine residues (L18H, L28H, L67H),
a histidine residue was replaced with valine (H72V) to ensure
no competition for ZnII binding, and four extra residues were
added to the end of the chain (GSGA) which improved
expression yields (Table 1). Expressed from a synthetic gene
in Escherichia coli, a3DH3 was purified by high-performance
liquid chromatography (HPLC) and characterized by electro-
spray ionization mass spectroscopy (EI-MS). The observed
molecular weight of 8283.5 Da corresponds to the protein
after deletion of the N-terminal methionine residue (MWcalc=
8283.1 Da). The protein is well-folded and stable according to
circular dichroism spectroscopy (Supporting Information,
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Figure S1). The observed double well at 208 and 222 nm is
characteristic of a-helical proteins, and the molar ellipticities
suggest that the protein is 82% folded at pH 9. Chemical
denaturations with guanidine hydrochloride were fit to a two-
state unfolding model, revealing a DGu= 3.1 kcalmol
1.
Although the histidine substitutions destabilized the protein
compared to native a3D (DGu= 5.1 kcalmol
1), the construct
is stable enough for use in kinetic studies. The presence of ZnII
caused no change in the folding or stability of a3DH3
(Supporting Information, Figure S1).
Apparent ZnII binding constants were measured by UV/
Vis spectroscopy using Zincon as a colorimetric probe
(Supporting Information, Figures S2–S4). a3DH3 binds Zn
II
with a 150 40 nm affinity at pH 7.5, which strengthens to
59 9 nm at pH 9.0. A control peptide, a3DH72V, which lacks
the His3 binding site, binds with 20-fold weaker affinity (Kd=
1.2 0.4 mm at pH 9.0), confirming that the histidine site is
involved in specific ZnII binding. These affinities are weaker
than that of CAII measured by equilibrium dialysis (Kd=
0.8 0.1 pm);[16] however, recent isothermal titration calorim-
etry experiments suggest a three-orders of magnitude weaker
affinity for CAII (Kd= 0.45 nm).
[17] Based on this newer
measurement, a3DH3 has an affinity only two orders
of magnitude weaker than CAII and stronger than
those observed for our previously published
HgIISZn
II
N(TRIL9CL23H)3 (Kd= 0.8 0.1 and 0.22
0.06 mm at pH 7.5 and 9.0, respectively).[18]
A sample of ZnIIa3DH3 at pH 9.0 was analyzed by
extended X-ray absorption fine structure (EXAFS) spectros-
copy. The EXAFS data is dominated by nearest-neighbor
scattering typical of oxygen or nitrogen ligation and can be
modeled with a single oxygen/nitrogen shell at about 1.98 ,
a distance consistent with a four-coordinate Zn site. There is
clear evidence of outer shell scattering typical of histidine
ligated metals (that is, features at R+a> 2  in Figure 2).
Given the relatively limited k range of these data, there are
multiple models with similar fit quality, making it difficult to
define the number of histidine ligands from EXAFS alone.
However, the best fit, both in terms of mean-square deviation
and in terms of the presence of physically reasonable fit
parameters, uses one oxygen at 1.90  and 3 histidines at
1.99 . These parameters are very similar to EXAFS
distances measured for CAII (Zn-N/O of 1.98 ).[17]
The true indication of a successfully designed metal-
loenzyme mimic is catalytic activity toward the physiological
reaction of the natural enzyme, in this case, the hydration of
CO2. Using Khalifs
[19] stopped-flow indicator technique,
ZnIIa3DH3 was found to be an efficient catalyst with activities
that increase with pH (Table 2). Testing the activity at a pH
higher than 9.5 is not feasible because the stability of the
bundle is compromised when interhelical salt bridges are
deprotonated. Fitting the catalytic efficiencies for pH 8–9.5,
a maximal efficiency of 6.9  104 Lmol1 s1 and a kinetic pKa
of 9.4 were derived (Figure 3). CAII has a pKa of 6.8
20 for
the deprotonation of ZnII-bound water to give the active
hydroxide complex. The pKa measured here might be
for the same process (as was suggested for the
observed pKa (8.8) for p-nitrophenylacetate hydrolysis by
HgIISZn
II
N(TRIL9CL23H)3); however, it could also be for
a lysine residue near the active site, which, upon deprotona-
tion, would open up the bundle and allow improved substrate
access. In either case, catalysis occurs at the ZnIIHis3O site;
even in the presence of ZnII the control peptide a3DH72V
shows significantly lower activity (Supporting Information,
Figure S5).
Numerous small molecule models for CAII have been
reported, with varying degrees of structural similarity to the
enzyme active site.[21–28] Many of these show some catalytic
activity toward the hydration of CO2, with the fastest catalysts
listed in Table 2. Both ZnII(tris(4,5-di-n-propyl-2-imidazolyl)-
Figure 1. PyMol[11] models of a3DH3 showing a) the entire bundle (last
four residues removed for simplicity) and b) the ZnIIHis3O site
incorporating EXAFS Zn-N/O distances. Models are based on the
NMR solution structure of a3D (PDB: 2A3D).
[12]
Table 1: Designed peptide sequences.[a]
Peptide Sequence
a3DH3 MGSWAEFKQRLAAIKTRHQALGG
SEAEHAAFEKEIAAFESELQAYKGKGNPE
VEALRKEAAAIRDEHQAYRVNGSGA
a3DH72V MGSWAEFKQRLAAIKTRLQALGG
SEAELAAFEKEIAAFESELQAYKGKGNPE
VEALRKEAAAIRDELQAYRVN
[a] Mutations with respect to a3D are in bold and italics.
Figure 2. Fourier transform (FT) of the EXAFS spectra for ZnIIa3DH3.
Inset is k3-weighted EXAFS spectra used to calculate the FT. c Ex-
perimental data, a best-fit curve.
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phosphine) and ZnII(nitrilotris(2-benzimidazolylmethyl-6-
sulfonate) have N3O coordination of the Zn
II ion and show
moderate activity.[25,28] ZnIIa3DH3 outperforms each of these
with a maximal catalytic efficiency that is at least 14-fold
higher than their fastest second-order rate constants. Its
efficiency is only 2.6-fold slower than that of
HgIISZn
II
N(TRIL9CL23H)3 (Table 2), the only other designed
enzyme for CO2 hydration.
[2] Compared to the native
enzymes, ZnIIa3DH3 is 1400-fold slower than CAII and only
11-fold slower than CAIII.[29,30]
A frequent problem with small-molecule models of
enzymes is product inhibition.[31–33] Using acetate as a more
tractable mimic of the reaction product bicarbonate, product
inhibition was tested (Supporting Information, Figure S5).
Addition of 300 mm KOAc to the assay at pH 8.5 resulted in
a decrease in kcat from 82 6 to 66 4 s1. With an enzyme
concentration of 100 mm and HCO3
 concentrations never
exceeding 25 mm, no significant loss in catalytic activity is
expected owing to product inhibition. This shows that the
peptide is well-designed to avoid product inhibition, high-
lighting one benefit of de novo design over small molecule
catalysts.
In conclusion, we successfully modified an existing
de novo designed protein to contain a ZnIIHis3 binding site
while retaining the desired fold. We report the first pH profile
for CO2 hydration by a de novo designed protein and show
that ZnIIa3DH3 catalyzes this reaction better than any small
molecule model and within 1–3 orders of magnitude of
natural CA isozymes. The efficiency of our single-stranded
construct is slightly lower than our previously reported 3SCC
HgIISZn
II
N(TRIL9CL23H)3 and the Zn
II affinity is stronger,
likely a consequence of differences in the peptide scaffolds.
The antiparallel bundle is expected to have a weaker dipole
than the coiled-coil, imidazole rings in less-symmetric ori-
entations, and different electrostatics around the binding site.
Compared to HgIISZn
II
N(TRIL9CL23H)3, Zn
IIa3DH3 has
greater potential for improving catalysis because it is far
easier to make asymmetric protein modifications in this
system. Furthermore, being an antiparallel construct,
ZnIIa3DH3 more faithfully reproduces helical structures
found in nature. In CAII, mutation of Thr199 to alanine
lowers the activity 100-fold, showcasing the importance of
second coordination sphere residues involved in hydrogen
bonds.[34] Future work will focus on site selective incorpo-
ration of acid–base catalytic residues or design of water
channels that may tune the Lewis acidity of ZnII to optimize
activity.
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Table 2: Kinetic parameters for the catalysis of CO2 hydration by enzymes and model complexes.
Enzyme/Model pKa pH kcat [s
1] KM [mm] kcat/KM [Lmol
1 s1] k2 [Lmol
1 s1] Reference
CAII 6.8[a] 8.8 8.2105 8.9 9.2107 [29]
CAIII 8.5 9.0 8103 20 4105 [30]
HgIISZn
II
N(TRIL9CL23H)3
n+ 8.82[b] 9.5 (1.80.4)103 10.02.4 (1.80.3)105 [2]
ZnIIa3DH3 9.4 9.5 1348 3.50.6 (3.80.5)104 this work
9.25 1378 4.10.7 (3.20.3)104
9.0 1038 4.91.0 (2.10.3)104
8.75 10712 7.31.8 (1.5(0.2)104
8.5 826 7.21.1 (1.10.1)104
8.0 394 6.21.7 (0.630.1)104
ZnII([14]aneN4) 9.8 ind[c] 5040[c] [35]
ZnII([12]aneN4) 8.1 9.1 3012193 [27]
ZnII(nitrilotris(2-benzimidazolylmethyl-6-sulfonate) 8.3 9.5 3180[d] [28]
ZnII(tris(4,5-di-n-propyl-2-imidazolyl)phosphine) 8.0 6.55 2480[e] [25]
[a] Taken from Ref. [20]. [b] pKa measured for the hydrolysis of pNPA. [c] pH-independent second-order rate constant (maximal rate) calculated using
pKa of 9.8 and measured rate of 690m
1 s1 at pH 9.0. [d] Second-order rate constant measured at 15 8C. [e] Second-order rate constant was measured
for the dehydration of HCO3
+H+ in 80% EtOH/H2O.
Figure 3. Plot of pH dependency of the catalytic efficiency of CO2
hydration by ZnII-a3DH3. Standard errors for the fit of the Michaelis–
Menten equation to each plot of initial rate versus initial [CO2]. The
buffer/indicator pairs used: ~ TAPS/m-cresol purple (pH 8-8.75),
* AMPSO/thymol blue (pH 8.75–9.25), & CHES/thymol blue
(pH 9.25–9.5).
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